[
  {
    "ts": null,
    "headline": "BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe",
    "summary": "BDX expands its BD MAX menu in Europe with IVDR-approved respiratory and STI assays, boosting system utility and reinforcing its diagnostics growth strategy.",
    "url": "https://finnhub.io/api/news?id=0d4bfe8e1b850ebd0d377841555219cb6aa0c90ac33c6a0cb9a410d2de9b162d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765903020,
      "headline": "BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe",
      "id": 137806692,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "BDX expands its BD MAX menu in Europe with IVDR-approved respiratory and STI assays, boosting system utility and reinforcing its diagnostics growth strategy.",
      "url": "https://finnhub.io/api/news?id=0d4bfe8e1b850ebd0d377841555219cb6aa0c90ac33c6a0cb9a410d2de9b162d"
    }
  },
  {
    "ts": null,
    "headline": "Ember LifeSciences secures $16.5 million Series A funding to advance breakthrough cold chain solutions for global healthcare",
    "summary": "Ember LifeSciences, Inc., a leading provider of revolutionary cold chain technology, today announced a $16.5 million Series A funding round, led by Sea Court Capital, with participation from Cardinal Health, Carrier Ventures and other influential investors, including former U.S. Secretary of State Mike Pompeo. The round underscores strong investor confidence in Ember LifeSciences' ability to redefine global medicine distribution through its proprietary temperature control technology.",
    "url": "https://finnhub.io/api/news?id=990ce432bf8b1e939bc9f2d8659e35aac654cadd9461d812aa3b3991bb532316",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765890000,
      "headline": "Ember LifeSciences secures $16.5 million Series A funding to advance breakthrough cold chain solutions for global healthcare",
      "id": 137806759,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Ember LifeSciences, Inc., a leading provider of revolutionary cold chain technology, today announced a $16.5 million Series A funding round, led by Sea Court Capital, with participation from Cardinal Health, Carrier Ventures and other influential investors, including former U.S. Secretary of State Mike Pompeo. The round underscores strong investor confidence in Ember LifeSciences' ability to redefine global medicine distribution through its proprietary temperature control technology.",
      "url": "https://finnhub.io/api/news?id=990ce432bf8b1e939bc9f2d8659e35aac654cadd9461d812aa3b3991bb532316"
    }
  }
]